Skip to main content
Top
Published in: Thrombosis Journal 1/2019

Open Access 01-12-2019 | Phlebothrombosis | Research

Chemoprophylaxis in addition to mechanical prophylaxis after total knee arthroplasty surgery does not reduce the incidence of venous thromboembolism

Authors: Jing Loong Moses Loh, Stephrene Chan, Keng Lin Wong, Sanjay de Mel, Eng Soo Yap

Published in: Thrombosis Journal | Issue 1/2019

Login to get access

Abstract

Background

Venous thromboembolism (VTE) of the lower limbs is an important complication post total knee arthroplasty (TKA). Current guidelines recommend routine chemical prophylaxis to all patients undergoing this procedure but this is rarely done in Asia as it is believed that Asians have a lower risk of VTE. However, recent evidence suggests otherwise.

Aims

We evaluated the incidence of DVT after TKA in a multi-ethnic Asian population with and without pharmacological prophylaxis, as well as the management and outcome of patients with post-operative DVTs.

Methods

We conducted a retrospective study of consecutive patients who underwent TKA in our hospital from 1st January 2004 to 30th December 2014. All patients were on mechanical thromboprophylaxis via calf pumps after TKA with a postoperative day 3 to 5 doppler ultrasound (DUS) of bilateral lower limbs. 2258 (80.7%) patients did not receive additional chemoprophylaxis, while 540 (19.3%) received chemoprophylaxis on top of mechanical thromboprophylaxis. All patients who received chemoprophylaxis were administered the drug until they were ambulating, with a median administration duration of 6 days. Patients were followed up for a period of 3 months for recurrence of DVTs and 24 months for postoperative outcome scores.

Results

Two thousand nine hundred seventy-eight patients had DUS of the lower limbs with 134 diagnosed with DVT giving an incidence of 4.5%. Six of these patients had concurrent PEs. There were 26 (19.4%) proximal DVTs and 108 (80.6%) distal DVTs. After 3 months of follow up, no additional VTE occurred. None of the DVTs or PEs progressed.
All DVTs with accompanying PE were proximal. 102 out of 2200 patients (4.6%) without chemoprophylaxis developed DVT as compared to 32 out of 540 patients (5.9%) with chemoprophylaxis, which was not statistically significant (p = 0.13). 19 (0.8%) proximal and 83 (3.8%) distal DVT developed in the patient group without chemoprophylaxis while 4 (0.7%) proximal and 28 (5.2%) distal DVT developed in the patient group with (p = 0.62). Comparison of the incidence of PEs between the two groups, revealed a similar incidence with 5 out of 2200 patients (0.2%) without chemoprophylaxis developing PE as compared to 1 out of 540 patients (0.2%) with chemoprophylaxis (p = 0.87).
In addition, patients with chemoprophylaxis showed an association with higher post-operative outcome scores such as post op 6 months SF36 (PCS), post op 12 months SF36 (PCS), post op 12 months SF36 (MCS), post op 24 months SF36 (MCS) and post op 24 months WOMAC.

Conclusion

In one of the largest Asian studies specifically investigating the incidence of DVT after TKA, we found that the incidence is low at 4.5%. This is in contrast to recent studies that showed higher post-operative VTE rates similar to Western populations. In addition, patients who were administered chemoprophylaxis did not have a statistically significant difference in incidence of VTE although it did show a correlation with higher post-operative outcome scores which may indicate better function. This was seen in functional outcome scores such as post op 6 months SF36 (PCS), post op 12 months SF36 (PCS), post op 12 months SF36 (MCS), post op 24 months SF36 (MCS) and post op 24 months WOMAC.
Literature
1.
go back to reference Steiner C, Andrews R, Barrett M, Weiss A. HCUP projections: mobility/orthopedic procedures 2003 to 2012. HCUP projections report# 2012–03 2012. US Agency for Healthcare Research and Quality. Steiner C, Andrews R, Barrett M, Weiss A. HCUP projections: mobility/orthopedic procedures 2003 to 2012. HCUP projections report# 2012–03 2012. US Agency for Healthcare Research and Quality.
2.
go back to reference Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):381–453.CrossRef Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):381–453.CrossRef
3.
go back to reference Cohen AT. Asia-Pacific thrombosis advisory board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost. 2010;104(05):919–30.PubMed Cohen AT. Asia-Pacific thrombosis advisory board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost. 2010;104(05):919–30.PubMed
4.
go back to reference Atichartakarn V, Pathepchotiwong K, Keorochana S, Eurvilaichit C. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med. 1988;148(6):1349–53.CrossRef Atichartakarn V, Pathepchotiwong K, Keorochana S, Eurvilaichit C. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med. 1988;148(6):1349–53.CrossRef
5.
go back to reference Kim YH, Suh JS. Low incidence of deep-vein thrombosis after cementless total hip. J Bone Joint Surg Am. 1988;70:878–82.CrossRef Kim YH, Suh JS. Low incidence of deep-vein thrombosis after cementless total hip. J Bone Joint Surg Am. 1988;70:878–82.CrossRef
6.
go back to reference Mok CK, Hoaglund FT, Rogoff SM, Chow SP, Yau AC. The pattern of deep-vein thrombosis and clinical course of a group of Hong Kong Chinese patients following hip surgery for fracture of the proximal femur. Clin Orthop Relat Res. 1980;(147):115–20. Mok CK, Hoaglund FT, Rogoff SM, Chow SP, Yau AC. The pattern of deep-vein thrombosis and clinical course of a group of Hong Kong Chinese patients following hip surgery for fracture of the proximal femur. Clin Orthop Relat Res. 1980;(147):115–20.
7.
go back to reference Lee LH. Clinical update on deep vein thrombosis in Singapore. Ann Acad Med Singap. 2002;31(2):248–52.PubMed Lee LH. Clinical update on deep vein thrombosis in Singapore. Ann Acad Med Singap. 2002;31(2):248–52.PubMed
8.
go back to reference Mont MA, Jacobs JJ, Boggio LN, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AJ Jr, Watters WC III, Turkelson CM, Wies JL. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg. 2011;19(12):768–76.CrossRef Mont MA, Jacobs JJ, Boggio LN, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AJ Jr, Watters WC III, Turkelson CM, Wies JL. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg. 2011;19(12):768–76.CrossRef
9.
go back to reference Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e278S–325S.CrossRef Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e278S–325S.CrossRef
10.
go back to reference Dhillon KS, Askander A, Doraisamy S. Postoperative deep-vein thrombosis in Asian patients is not a rarity: a prospective study of 88 patients with no prophylaxis. J Bone Joint Surg Br. 1996;78(3):427–30.CrossRef Dhillon KS, Askander A, Doraisamy S. Postoperative deep-vein thrombosis in Asian patients is not a rarity: a prospective study of 88 patients with no prophylaxis. J Bone Joint Surg Br. 1996;78(3):427–30.CrossRef
11.
go back to reference Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. JBJS. 2007;89(1):33–8.CrossRef Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. JBJS. 2007;89(1):33–8.CrossRef
12.
go back to reference Lyder CH. Pressure ulcer prevention and management. Jama. 2003;289(2):223–6.CrossRef Lyder CH. Pressure ulcer prevention and management. Jama. 2003;289(2):223–6.CrossRef
13.
go back to reference Fuji T, Nakamura M, Takeuchi M. Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies. Clin Appl Thromb Hemost. 2014;20(2):199–211.CrossRef Fuji T, Nakamura M, Takeuchi M. Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies. Clin Appl Thromb Hemost. 2014;20(2):199–211.CrossRef
14.
go back to reference Kanchanabat B, Stapanavatr W, Meknavin S, Soorapanth C, Sumanasrethakul C, Kanchanasuttirak P. Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg. 2011;98(10):1356–64.CrossRef Kanchanabat B, Stapanavatr W, Meknavin S, Soorapanth C, Sumanasrethakul C, Kanchanasuttirak P. Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg. 2011;98(10):1356–64.CrossRef
15.
go back to reference Bellamy N. WOMAC Osteoarthritis index: a user's guide. London, Ontario: University of Western Ontario; 1996. Bellamy N. WOMAC Osteoarthritis index: a user's guide. London, Ontario: University of Western Ontario; 1996.
16.
go back to reference Gandek B, Ware JE Jr, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplège A. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. J. Clin. Epidemiol. 1998;51(11):1149–58.CrossRef Gandek B, Ware JE Jr, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplège A. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. J. Clin. Epidemiol. 1998;51(11):1149–58.CrossRef
17.
go back to reference Zhou Z, Yew AK, Chin PL, Lo NN, Yeo SJ, Chia SL. Total knee arthroplasty complicated by distal deep venous thromboembolism: does it affect the functional outcome? Proceedings of Singapore Healthcare. 2013;22(4):262–6.CrossRef Zhou Z, Yew AK, Chin PL, Lo NN, Yeo SJ, Chia SL. Total knee arthroplasty complicated by distal deep venous thromboembolism: does it affect the functional outcome? Proceedings of Singapore Healthcare. 2013;22(4):262–6.CrossRef
18.
go back to reference Hill J, Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart. 2010;96(11):879–82.CrossRef Hill J, Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart. 2010;96(11):879–82.CrossRef
19.
go back to reference Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 1;141(2):e419S–96S.CrossRef Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 1;141(2):e419S–96S.CrossRef
20.
go back to reference Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009;135(2):513–20.CrossRef Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009;135(2):513–20.CrossRef
21.
go back to reference Sharfman ZT, Campbell JC, Mirocha JM, Spitzer AI. Balancing thromboprophylaxis and bleeding in total joint arthroplasty: impact of eliminating enoxaparin and predonation and implementing pneumatic compression and tranexamic acid. J arthroplasty. 2016;31(6):1307–12.CrossRef Sharfman ZT, Campbell JC, Mirocha JM, Spitzer AI. Balancing thromboprophylaxis and bleeding in total joint arthroplasty: impact of eliminating enoxaparin and predonation and implementing pneumatic compression and tranexamic acid. J arthroplasty. 2016;31(6):1307–12.CrossRef
22.
go back to reference Cusick LA, Beverland DE. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients. J Bone Joint Surg Br. 2009;91(5):645–8.CrossRef Cusick LA, Beverland DE. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients. J Bone Joint Surg Br. 2009;91(5):645–8.CrossRef
23.
go back to reference Sharrock NE, Della Valle AG, Go G, Lyman S, Salvati EA. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 2008;466(3):714–21.CrossRef Sharrock NE, Della Valle AG, Go G, Lyman S, Salvati EA. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 2008;466(3):714–21.CrossRef
24.
go back to reference Wong KL, Daguman R, Lim KH, Shen L, Lingaraj K. Incidence of deep vein thrombosis following total hip arthroplasty: a Doppler ultrasonographic study. J Orthop Surg. 2011;19(1):50–3.CrossRef Wong KL, Daguman R, Lim KH, Shen L, Lingaraj K. Incidence of deep vein thrombosis following total hip arthroplasty: a Doppler ultrasonographic study. J Orthop Surg. 2011;19(1):50–3.CrossRef
25.
go back to reference Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM. Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc. 2000;99(11):848–53.PubMed Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM. Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc. 2000;99(11):848–53.PubMed
26.
go back to reference Ko PS, Chan WF, Siu TH, Khoo J, Wu WC, Lam JJ. Deep venous thrombosis after total hip or knee arthroplasty in a “low-risk” Chinese population. J Arthroplast. 2003;18(2):174–9.CrossRef Ko PS, Chan WF, Siu TH, Khoo J, Wu WC, Lam JJ. Deep venous thrombosis after total hip or knee arthroplasty in a “low-risk” Chinese population. J Arthroplast. 2003;18(2):174–9.CrossRef
27.
go back to reference Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, Turpie AG, Gallus AS, Planès A, Passera R, Rouillon A. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3(12):2664–70.CrossRef Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, Turpie AG, Gallus AS, Planès A, Passera R, Rouillon A. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3(12):2664–70.CrossRef
28.
go back to reference Colwell CW Jr, Froimson MI, Mont MA, Ritter MA, Trousdale RT, Buehler KC, Spitzer A, Donaldson TK, Padgett DE. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. JBJS. 2010;92(3):527–35.CrossRef Colwell CW Jr, Froimson MI, Mont MA, Ritter MA, Trousdale RT, Buehler KC, Spitzer A, Donaldson TK, Padgett DE. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. JBJS. 2010;92(3):527–35.CrossRef
29.
go back to reference Clayville LR, Anderson KV, Miller SA, Onge EL. New options in anticoagulation for the prevention of venous thromboembolism and stroke. Pharmacy and Therapeutics. 2011;36(2):86.PubMedPubMedCentral Clayville LR, Anderson KV, Miller SA, Onge EL. New options in anticoagulation for the prevention of venous thromboembolism and stroke. Pharmacy and Therapeutics. 2011;36(2):86.PubMedPubMedCentral
30.
go back to reference Gelfer Y, Tavor H, Oron A, Peer A, Halperin N, Robinson D. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin. J arthroplasty. 2006;21(2):206–14.CrossRef Gelfer Y, Tavor H, Oron A, Peer A, Halperin N, Robinson D. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin. J arthroplasty. 2006;21(2):206–14.CrossRef
31.
go back to reference White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11–7.CrossRef White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11–7.CrossRef
32.
go back to reference Tinckler LF. Absence of pulmonary embolism in asians? Br Med J. 1964;1(5381):502.CrossRef Tinckler LF. Absence of pulmonary embolism in asians? Br Med J. 1964;1(5381):502.CrossRef
33.
go back to reference Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85(11):1334–7.CrossRef Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85(11):1334–7.CrossRef
34.
go back to reference De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341(11):801–6.CrossRef De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 1999;341(11):801–6.CrossRef
35.
go back to reference Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost. 1999;81(05):733–8.CrossRef Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost. 1999;81(05):733–8.CrossRef
36.
go back to reference Li F, Wang X, Huang W, Ren W, Cheng J, Zhang M, Zhao Y. Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb. Phlebology. 2014;29(7):442–6.CrossRef Li F, Wang X, Huang W, Ren W, Cheng J, Zhang M, Zhao Y. Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb. Phlebology. 2014;29(7):442–6.CrossRef
Metadata
Title
Chemoprophylaxis in addition to mechanical prophylaxis after total knee arthroplasty surgery does not reduce the incidence of venous thromboembolism
Authors
Jing Loong Moses Loh
Stephrene Chan
Keng Lin Wong
Sanjay de Mel
Eng Soo Yap
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2019
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-019-0200-1

Other articles of this Issue 1/2019

Thrombosis Journal 1/2019 Go to the issue